Clinuvel Pharmaceuticals (UR9A.F) Q1 2023 Earnings

24FebConfirmed
Q3 2021
Q1 2022
Q3 2022
Q1 2023
0.07
0.12
0.17
0.22

Details

Expected EPS
0.1970133331467435
Actual EPS
0.13981591384607603
Surprise EPS
-0.06
Surprise Percent
+29.03%

Description

Clinuvel Pharmaceuticals (UR9A.F) has reported earnings of 0.13981591384607603 per share for Q1 2023.

0 Comments

Share your thoughts